Massachusetts Financial Services CO Repligen Corp Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
BUY
$154.26 - $198.1 $445,965 - $572,707
2,891 Added 1.09%
267,374 $45 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $11.4 Million - $15.4 Million
69,933 Added 35.95%
264,483 $44.8 Million
Q3 2022

Nov 09, 2022
BUY
$160.42 - $256.21 $31.2 Million - $49.8 Million
194,550 New
194,550 $36.4 Million

Others Institutions Holding RGEN

# of Institutions
485
Shares Held
54.1M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email